Filing Details

Accession Number:
0000059478-17-000144
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-08 15:44:17
Reporting Period:
2017-05-04
Filing Date:
2017-05-08
Accepted Time:
2017-05-08 15:44:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1476151 A Enrique Conterno Lilly Corporate Center
Indianapolis IN 46285
Svp&pres, Lillydiab & Lillyusa No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-05-04 25,000 $82.76 114,217 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,955 Indirect 401(k)
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $82.67 to $82.86. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.